|
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for certified healthcare advice, trips or professional assistance with a real dr.. We are not physicians. Always consult your physician about Johnson & Johnson Pharmaceutical Research and Development, L.L.C. clinical studies. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical research trials and Johnson & Johnson Pharmaceutical Research and Development, L.L.C. health trials happen in a lot of of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out specific human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies like Johnson & Johnson Pharmaceutical Research and Development, L.L.C. to find remedies for all forms of conditions. Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trials and other clinical trials permit volunteers to have health treatment choices before they are available to the masses. Most times the test subjects acquire treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Johnson & Johnson Pharmaceutical Research and Development, L.L.C. clinical trial. Human subjects often receive the most effective healthcare possible for their condition. Risks are a reality, nonetheless, and can include additional or frequent dr. trips, healthcare risks (potentially life-jeopardising), and/or the treatment being uneffective. Trials are federally regulated with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "J" Clinical Trials Sponsors > Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trials
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trials
3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects with Major Depressive Disorder
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Phase 2 study of ET-743 in subjects with advanced breast cancer
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Placebo Controlled Trial to evaluate the safety and efficacy of Galantamine in the treatment of vascular dementia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Study of the Safety and Efficacy of Topiramate in the Treatment of Patients with Bipolar I Disorder
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A Study of the Safety and Efficacy of Topiramate in the Treatment of Patients with Bipolar I Disorder
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
A study to evaluate the safety and effectiveness of topiramate compared to placebo in the treatment of Bipolar I Disorder.
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Efficacy and safety study of letrozole plus ZARNESTRA or placebo in the treatment of advanced breast cancer.
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Efficacy and safety study of ZARNESTRA(tm) in subjects with High-risk Myelodysplastic Syndrome (MDS).
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
ET-743 in Men with Advanced Prostate Cancer
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Extended Release OROS Paliperidone in treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects with Schizophrenia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers with Regranex or Placebo
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Open label trial exploring a switch from oral medications, to risperidone depot microspheres
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Pediatric Community-Acquired Pneumonia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Phase 2 study of ET-743 in persistent or recurrent endometrial carcinoma
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Phase 2 study of ET-743 in subjects with advanced ovarian cancer
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Phase 2 Study of ZARNESTRA™ as Postconsolidation Therapy for Acute Myeloid Leukemia in Subjects 60 Years & Older
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Safety and efficacy of an anti-psychotic in subjects with schizophrenia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Safety and efficacy of study drug versus placebo for negative symptoms of schizophrenia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Short Course Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) (750 mg)
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Study of Levofloxacin to Evaluate Bacteriologic Outcome In Children with Difficult To Treat Acute Otitis Media
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Study to determine the effectiveness of risperidone in bipolar disorder in children and adolescents
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
The Efficacy and Safety of Risperidone in the Treatment of Adolescents with Schizophrenia
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Treatment of Anemia in Patients with Cancer who Are Not Currently Receiving Chemotherapy or Radiotherapy
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Treatment of Anemic Patients with Cancer who are not Receiving Chemotherapy or Radiotherapy
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Treatment Resistant Depression Study
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Trial Evaluating the Safety and Efficacy of 2 Doses of ER OROS Paliperidone in Acute Adult Schizophrenics
Condition: johnson__johnson_pharmaceutical_research_and_development_llc_clinical_trials.html
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trials
|
|
|
|
|
|
|
|
